CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. The purpose of this amendment is to provide authority to address the National Emergency by providing Emergency Use Authority for investigational drugs, devices, and biological agents and their administration, as well as by increasing the payment for COVID-19 vaccine administration to 100% of the Medicare rate and by providing authority for an Alternative Payment Methodology to specific providers for COVID-19 vaccine administration.
State
Approval Date
Effective Date
File 1 - Approval Document Media